ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
EAP treatment completed and Orphan Status achieved for MPS-I
Published: 30/04/20, 10:24am (AEST)•3 pages